Sign In
Buy AWH
$0.0820
+0 (+0%)
At Close: Jul 30, 2025
Aspira Women's Health Inc. (AWH) Q2 2024 Earnings Call Transcript
08:34pm, Monday, 12'th Aug 2024
Aspira Women's Health Inc. (NASDAQ:AWH ) Q2 2024 Earnings Conference Call August 12, 2024 4:30 PM ET Company Participants Nicole Sandford - CEO and Director Sandy Milligan - President Conference Call
Aspira (AWH) Reports Q2 Loss, Misses Revenue Estimates
06:21pm, Monday, 12'th Aug 2024
Aspira (AWH) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.28 per share a year ago.
Aspira Women's Health Reports Second Quarter 2024 Financial Results
04:05pm, Monday, 12'th Aug 2024
Q2 2024 OvaSuite S M revenue of $2.4 million and volume of 6,471 units
AUSTIN, Texas, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gynecologic diseas
AWH ANNOUNCES Q2 2024 FINANCIAL RESULTS
07:10am, Monday, 05'th Aug 2024
Achieved $141.5M Net Revenue in Q2 2024 , a 15% Increase Year-Over-Year Reported $28.3 million in Adjusted EBITDA, a 33% Increase Year-Over-Year Generated Positive Cash from Operations and Free C
Aspira Women's Health Announces Closing of $1.9 Million Private Placement Equity Financing
12:12pm, Tuesday, 09'th Jul 2024
AUSTIN, Texas, July 09, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development
AWH to Hold Second Quarter 2024 Earnings Conference Call on Monday, August 5, 2024
07:10am, Monday, 08'th Jul 2024
NEW YORK , July 8, 2024 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH" or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a leading multi-state, vertically integrated cannabis operator, today ann
Aspira Women's Health Announces $1.935 Million Private Placement Equity Financing
05:24pm, Monday, 01'st Jul 2024
AUSTIN, Texas, July 01, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development
Aspira Women's Health Provides Commercial, Reimbursement and Cash Guidance Updates
08:00am, Thursday, 13'th Jun 2024
Monthly OvaSuiteSM product volume grew by more than 26% in May compared to January Reimbursement momentum continued with expanded Anthem and Medicaid coverage for OvaSuite Cash used in operations gu
Aspira Women's Health to Present at the A.G.P. Healthcare Showcase on May 21
08:00am, Thursday, 16'th May 2024
AUSTIN, Texas, May 16, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development o
Aspira Women's Health Inc. (AWH) Q1 2024 Earnings Call Transcript
11:50am, Wednesday, 15'th May 2024
Aspira Women's Health Inc. (NASDAQ:AWH ) Q1 2024 Results Conference Call May 15, 2024 8:30 AM ET Company Participants Nicole Sandford - CEO Sandy Milligan - President Torsten Hombeck - CFO Conference
Aspira (AWH) Reports Q1 Loss, Tops Revenue Estimates
09:40am, Wednesday, 15'th May 2024
Aspira (AWH) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $10.94 per share a year ago.
Aspira Women's Health Reports First Quarter 2024 Financial Results
07:30am, Wednesday, 15'th May 2024
Q1 2024 OvaSuite S M revenue of $2.2 million and volume of 5,829 units
UPDATE -- Aspira Women's Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
08:47am, Wednesday, 08'th May 2024
AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development o
Aspira Women's Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
08:00am, Wednesday, 08'th May 2024
AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development o
